188 related articles for article (PubMed ID: 14593476)
1. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.
Lucht A; Grunow R; Otterbein C; Möller P; Feldmann H; Becker S
Med Microbiol Immunol; 2004 Nov; 193(4):181-7. PubMed ID: 14593476
[TBL] [Abstract][Full Text] [Related]
2. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
Yu JS; Liao HX; Gerdon AE; Huffman B; Scearce RM; McAdams M; Alam SM; Popernack PM; Sullivan NJ; Wright D; Cliffel DE; Nabel GJ; Haynes BF
J Virol Methods; 2006 Nov; 137(2):219-28. PubMed ID: 16857271
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus.
Lucht A; Grunow R; Möller P; Feldmann H; Becker S
J Virol Methods; 2003 Jul; 111(1):21-8. PubMed ID: 12821193
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins.
Yu JS; Ma BJ; Scearce RM; Liao HX; Haynes BF
J Virol Methods; 2010 Sep; 168(1-2):248-50. PubMed ID: 20447422
[TBL] [Abstract][Full Text] [Related]
5. Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus.
Zai J; Yi K; Xie L; Zhu J; Feng X; Li Y
Diagn Pathol; 2018 Dec; 13(1):96. PubMed ID: 30567559
[TBL] [Abstract][Full Text] [Related]
6. The induction and characterization of monoclonal antibodies specific to GP of Ebola virus.
Tian X; Chen D; Wang H; Xu S; Zhu L; Wu X; Wu Z
J Med Virol; 2020 Aug; 92(8):996-1006. PubMed ID: 31663613
[TBL] [Abstract][Full Text] [Related]
7. Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.
Krähling V; Becker D; Rohde C; Eickmann M; Eroğlu Y; Herwig A; Kerber R; Kowalski K; Vergara-Alert J; Becker S;
Med Microbiol Immunol; 2016 Apr; 205(2):173-83. PubMed ID: 26475282
[TBL] [Abstract][Full Text] [Related]
8. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
9. Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.
DeMers HL; He S; Pandit SG; Hannah EE; Zhang Z; Yan F; Green HR; Reyes DF; Hau D; McLarty ME; Altamura L; Taylor-Howell C; Gates-Hollingsworth MA; Qiu X; AuCoin DP
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008817. PubMed ID: 33141837
[TBL] [Abstract][Full Text] [Related]
10. Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.
Rodríguez-Martínez LM; Marquez-Ipiña AR; López-Pacheco F; Pérez-Chavarría R; González-Vázquez JC; González-González E; Trujillo-de Santiago G; Ponce-Ponce de León CA; Zhang YS; Dokmeci MR; Khademhosseini A; Alvarez MM
PLoS One; 2015; 10(10):e0135859. PubMed ID: 26489048
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
[TBL] [Abstract][Full Text] [Related]
12. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
[TBL] [Abstract][Full Text] [Related]
13. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model.
Lee HN; McWilliams IL; Lewkowicz AP; Engel K; Ireland DDC; Kelley-Baker L; Thacker S; Piccardo P; Manangeeswaran M; Verthelyi D
Emerg Microbes Infect; 2021 Dec; 10(1):2076-2089. PubMed ID: 34674613
[TBL] [Abstract][Full Text] [Related]
15. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
[TBL] [Abstract][Full Text] [Related]
16. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM
Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
[TBL] [Abstract][Full Text] [Related]
18. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
Qiu X; Alimonti JB; Melito PL; Fernando L; Ströher U; Jones SM
Clin Immunol; 2011 Nov; 141(2):218-27. PubMed ID: 21925951
[TBL] [Abstract][Full Text] [Related]
20. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.
Ikegami T; Niikura M; Saijo M; Miranda ME; Calaor AB; Hernandez M; Acosta LP; Manalo DL; Kurane I; Yoshikawa Y; Morikawa S
Clin Diagn Lab Immunol; 2003 Jul; 10(4):552-7. PubMed ID: 12853385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
